30147912|t|Metabolic acidosis after sodium thiosulfate infusion and the role of hydrogen sulfide.
30147912|a|Sodium thiosulfate (STS), first-line treatment for calcific uremic arteriolopathy, causes a mild asymptomatic acidosis in many patients. However, severe, life-threatening acidosis out of proportion with the expected acid load of STS may occur, potentially due to metabolism of STS to hydrogen sulfide.
30147912	0	18	Metabolic acidosis	Disease	MESH:D000138
30147912	25	43	sodium thiosulfate	Chemical	MESH:C017717
30147912	69	85	hydrogen sulfide	Chemical	MESH:D006862
30147912	87	105	Sodium thiosulfate	Chemical	MESH:C017717
30147912	107	110	STS	Chemical	MESH:C017717
30147912	147	168	uremic arteriolopathy	Disease	MESH:D006463
30147912	197	205	acidosis	Disease	MESH:D000138
30147912	214	222	patients	Species	9606
30147912	258	266	acidosis	Disease	MESH:D000138
30147912	316	319	STS	Chemical	MESH:C017717
30147912	364	367	STS	Chemical	MESH:C017717
30147912	371	387	hydrogen sulfide	Chemical	MESH:D006862
30147912	Comparison	MESH:C017717	MESH:D006862
30147912	Negative_Correlation	MESH:C017717	MESH:D006463
30147912	Positive_Correlation	MESH:C017717	MESH:D000138

